CHF155.50
4.72% today
SIX Swiss Exchange, Apr 03, 01:45 pm CET
ISIN
CH0012100191
Symbol
TECN
Sector

Tecan Group Ltd. Stock price

CHF163.20
-32.80 16.73% 1M
-113.80 41.08% 6M
-39.40 19.45% YTD
-204.40 55.60% 1Y
-215.40 56.89% 3Y
-135.60 45.38% 5Y
+36.70 29.01% 10Y
SIX Swiss Exchange, Closing price Wed, Apr 02 2025
-0.70 0.43%
ISIN
CH0012100191
Symbol
TECN
Sector

Key metrics

Market capitalization CHF2.08b
Enterprise Value CHF1.99b
P/E (TTM) P/E ratio 30.79
EV/FCF (TTM) EV/FCF 14.63
EV/Sales (TTM) EV/Sales 2.13
P/S ratio (TTM) P/S ratio 2.22
P/B ratio (TTM) P/B ratio 1.45
Dividend yield 1.84%
Last dividend (FY24) CHF3.00
Revenue growth (TTM) Revenue growth -13.04%
Revenue (TTM) Revenue CHF934.28m
EBIT (operating result TTM) EBIT CHF69.08m
Free Cash Flow (TTM) Free Cash Flow CHF136.19m
EPS (TTM) EPS CHF5.30
P/E forward 26.92
P/S forward 2.20
EV/Sales forward 2.11
Show more

Is Tecan Group Ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Tecan Group Ltd. Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Tecan Group Ltd. forecast:

2x Buy
25%
6x Hold
75%

Analyst Opinions

8 Analysts have issued a Tecan Group Ltd. forecast:

Buy
25%
Hold
75%

Financial data from Tecan Group Ltd.

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Dec '24
+/-
%
934 934
13% 13%
100%
- Direct Costs 614 614
10% 10%
66%
321 321
18% 18%
34%
- Selling and Administrative Expenses 116 116
4% 4%
12%
- Research and Development Expense 68 68
2% 2%
7%
136 136
32% 32%
15%
- Depreciation and Amortization 67 67
6% 6%
7%
EBIT (Operating Income) EBIT 69 69
46% 46%
7%
Net Profit 68 68
49% 49%
7%

In millions CHF.

Don't miss a Thing! We will send you all news about Tecan Group Ltd. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Tecan Group AG operates as a holding company. The firm engages in the development, production and distribution of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. It operates through the following segments: Life Sciences Business and Partnering Business. The Life Sciences Business segment supplies end users with automated workflow solutions, which includes laboratory instruments, software packages, application know-how, services, consumables and spare parts. The Partnering Business segment develops and manufactures original equipment manufacturer instruments and components. The company was founded by Heinz Abplanalp, Heini Maurer, Heini Moeckli and Gallus Blatter on March 18, 1980 and is headquartered in Mannedorf, Switzerland.

Head office Switzerland
CEO Achim Leoprechting
Employees 3,591
Founded 1980
Website www.tecan.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today